| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |